EBOLA: IMPACT AND RESPONSE

EBOLA

Keywords: EBOLA, NEW EBOLA VACCINE

Abstract

Ebola virus disease (EVD) is a severe illness caused by  Ebola viruses affecting man and non human primates.  This Ebola hemorrhagic fever (EHF) or simply Ebola, is often deadly in nature. The virus is transmitted to man from wild animals such as fruit bats. It is thought that fruit bats of the Pteropodidae family are natural Ebola virus host and act as normal carrier in nature. The WHO affirmed the EVD outbreak as a “Public Health Emergency of International Concern” on August 8th, 2014. EVD is manifested by fever, fatigue, muscle, pain, headache, and sore throat. There is no proven treatment for Ebola. Simple interventions can significantly improve chances of survival. Supportive treatment includes rehydration with fluids and body salts.. EVD has a risk of death in those infected, between 25% and 90%. Rapid geographic dissemination, nonspecific clinical presentation, lack of vaccine, and specific diagnostic test are the possible challenges to combat this dreaded public health menace. Hand hygiene is the most effective way to prevent the spread of the Ebola virus. Ebola vaccine candidates against Ebola have been developed in the decade prior to 2014, but none have yet been approved for clinical use in humans. Most recently, the European Medicines Agency (EMA) has approved the first ever Ebola vaccine (rVSV-ZEBOV-GP vaccine). This development has been appreciated from all the corners as it is in the interest of mankind and will always be considered as an important milestone in the field of public health.

 

Downloads

Download data is not yet available.

Author Biographies

Abdullah A. Alsabaani, KING KHALID UNIVERSITY

1 Dr. Abdullah A. Alsabaani

Assistant Professor, Department of Family & Community Medicine, College of Medicine.

Dean, College of Applied Medical Sciences - Khamis Mushait Campus.

Director, Health Research Consultancy Office, Research and Consulting Studies Institute.

Director, Saudi Board of Preventive Medicine - Aseer Residency Program, SCFHS.

King Khalid University, Abha, Kingdom of Saudi Arabia

ORCID ID   https://orcid.org/0000-0003-2352-8249

Syed Esam Mahmood, KING KHALID UNIVERSITY

3 Dr. Syed Esam Mahmood

Professor, Department of Family & Community Medicine, College of Medicine,

King Khalid University, Abha, Kingdom of Saudi Arabia.

ORCID ID   https://orcid.org/0000-0001-5264-5677

Published
2019-12-31
How to Cite
1.
Alsabaani AA, Muzammil K, Mahmood SE. EBOLA: IMPACT AND RESPONSE . Indian J Community Health [Internet]. 2019Dec.31 [cited 2020Feb.26];31(4):428 -430. Available from: http://www.iapsmupuk.org/journal/index.php/IJCH/article/view/1282
Section
Editorial